R3 Bio Wants to Grow Brainless Copies of Your Body — Tim Draper Already Invested

:dna: R3 Bio Wants to Grow Brainless Copies of Your Body — Tim Draper Already Invested

A stealth startup just pitched Silicon Valley billionaires on growing your personal headless clone in a vat. For spare parts. I’m not making this up.

A Richmond, California startup called R3 Bio has been secretly pitching investors on growing human “bodyoids” — cloned copies of your body with just enough brain to stay alive, but not enough to think, feel, or be a person. The idea: harvest their organs when yours wear out. Or — and I need you to sit down for this — transplant your entire brain into the younger clone body.

Investors include Tim Draper (yes, that Tim Draper), the Immortal Dragons fund, and LongGame Ventures. The founder wrote a whole technical roadmap for it in 2023. They’ve been keeping this quiet because — and this is a direct quote — they fear “clickbait headlines and public backlash.” Buddy, I wonder why.

Clone Vat


🧩 Dumb Mode Dictionary
Term What It Actually Means
Bodyoid A lab-grown human body with no real brain — basically a living organ warehouse
Body Replacement Cloning Growing a younger copy of yourself so you can swap your brain into it later
Nonsentient Can’t think, feel, or experience anything — alive the way a plant is alive
Organ Sack Their literal words for a brainless monkey clone they want to grow for organ harvesting
Life Extension The rich-person hobby of trying to live forever instead of just going to therapy
Brain Transplant Moving your brain from your old body into a fresh one — currently sci-fi, they want to make it real
🔬 What R3 Bio Actually Does (vs. What They Dream About)

Okay so here’s where it gets important to separate the “real” from the “absolutely cooked.”

What they’ve actually done:

  • Cloned rodents. That’s it. Mice and rats
  • Raised money (amount undisclosed) from longevity-obsessed VCs
  • Written a technical roadmap document from 2023 outlining how you’d theoretically engineer animals without complete brains

What they’re pitching:

  • Growing brainless monkey “organ sacks” from a base in the Caribbean (because US regulations would shut this down immediately)
  • Eventually doing the same with human cells — your DNA, your clone, your spare parts
  • The final boss: full brain transplant into a younger cloned version of yourself

Nobody has EVER cloned a primate. They went from “we cloned some mice” to “we’ll grow brainless human bodies for billionaires” in one pitch deck. The audacity is genuinely breathtaking.

💰 Who's Funding This Fever Dream
  • Tim Draper — Silicon Valley billionaire, early Bitcoin investor, famously funded Theranos. So his track record on “sounds wild, is it real?” is… mixed
  • Immortal Dragons Fund — a longevity-focused investment fund whose name sounds like a World of Warcraft guild
  • LongGame Ventures — literally named after the concept of not dying
  • Various unnamed longevity enthusiasts who heard the pitch in secret meetings and — according to MIT Technology Review — described it as a “close encounter of the third kind” meets “Dr. Strangelove”

The fundraising was done to support testing cloning techniques in monkeys, operated from a Caribbean island to dodge US bioethics oversight. I mean. That sentence alone belongs in a movie.

⚖️ Why Scientists Are Screaming
  • Neuroscientist Bjorn Merker straight up said harvesting organs from organisms like this “would be unethical” — even if they technically can’t think
  • The question nobody can answer: how do you PROVE something has zero consciousness? What if “just enough brain to stay alive” is also “just enough brain to suffer”?
  • Growing a human body without a brain has never been done. We don’t even understand consciousness well enough to know what minimum brain structure actually means
  • US law effectively bans human cloning. That’s why they’re operating from the Caribbean. Which is… not the reassuring detail they think it is
  • First customers would be ultra-rich people who can afford a personal clone body. So we’re talking about a world where billionaires get spare bodies and everyone else gets a GoFundMe for insulin
🗣️ What People Are Actually Saying
Who What They Said
R3 Bio founder John Schloendorn “Replacement is probably better than repair” — meaning growing new parts beats fixing old ones
Anonymous pitch attendee Compared the presentation to a “close encounter of the third kind”
Longevity community insiders Kept the whole thing SECRET because they feared public backlash. Their literal words
Bjorn Merker (neuroscientist) Called organ harvesting from these organisms “unethical”
Bioethicists broadly This is “The Island” (the 2005 movie) becoming real and nobody asked for this

The longevity community’s strategy of “let’s do the most ethically explosive thing imaginable and just… not tell anyone” is peak Silicon Valley.

📊 The Receipts
Fact Detail
Company R3 Bio, Richmond, California
Founder John Schloendorn
Largest achievement to date Cloned rodents
Target species (next) Monkeys, from Caribbean lab
Ultimate goal Brainless human clone bodies
Key investors Tim Draper, Immortal Dragons, LongGame Ventures
Roadmap written 2023
US legal status of human cloning Effectively banned
Has anyone ever cloned a primate? No
Estimated cost per clone body Not disclosed (but obviously enormous)

Cool. A startup wants to grow your spare body in a vat like a sourdough starter. Now What the Hell Do We Do? ( ͡° ͜ʖ ͡°)

Spare Parts

🧊 The Bioethics Bounty Hunter

Every new biotech company doing anything remotely controversial needs ethics consultants, review board prep, and regulatory strategy docs BEFORE they talk to the FDA or any government body. R3 Bio is just the loudest — there are dozens of stealth longevity startups doing sketchy stuff quietly. Position yourself as the person who writes their “why this isn’t evil” documentation package. Regulatory translation (turning science-speak into government-speak) is a skill almost nobody has.

:brain: Example: A 26-year-old pre-law grad in São Paulo, Brazil builds a template pack of bioethics review documents by studying FDA guidance archives and EU clinical trial regulations. Sells the templates through Gumroad to longevity startups who need to look legit before investor meetings. Gets $4,200 in the first month from 14 companies.

:chart_increasing: Timeline: First sale in 12 days. Steady income for 6-8 months until bigger consultancies copy the format.

🪞 The Clone Panic Content Mill

This story is going to dominate dinner tables, podcasts, and social feeds for weeks. But most people won’t understand the science — they’ll just be scared. The gap between “people freaking out” and “anyone explaining it clearly” is massive right now. Build short explainer threads, infographics, and comparison charts (what’s legal vs illegal, what’s real vs theoretical, what’s 2026 vs 2050). Post them on every platform. Monetize through a Substack or Ko-fi where the deeper breakdowns live.

:brain: Example: A 22-year-old biology student in Lagos, Nigeria creates a series of visual explainer posts on Instagram and X comparing R3 Bio’s claims to actual cloning science capabilities. The thread goes viral (180K impressions). Drives 900 subscribers to her paid Substack at $5/month within the first two weeks.

:chart_increasing: Timeline: First viral post in 3 days if you ride the news cycle. Revenue within 2 weeks. Relevance window: ~6 weeks before the next scandal takes over.

🔍 The Longevity Investor Dossier

Longevity is a $600B+ industry and growing. But most investors in this space are terrible at due diligence because the science is so weird nobody can tell what’s real. Build a private research service that tracks every stealth longevity startup, their claims, their ACTUAL capabilities, and their regulatory status. Sell access as a monthly intelligence brief to angel investors and family offices. You’re not selling advice — you’re selling “don’t be the next person who funded Theranos.”

:brain: Example: A 30-year-old ex-pharma researcher in Kraków, Poland scrapes SEC filings, patent databases, and ClinicalTrials.gov data to build a longevity startup tracker. Packages it as a $200/month newsletter for angel investors. Gets 40 subscribers in 6 weeks through cold outreach on LinkedIn to biotech VCs. That’s $8,000/month.

:chart_increasing: Timeline: First paying subscriber in 18 days. Plateau at ~100 subscribers ($20K/month) within 4 months. This one compounds — the longer you track, the more valuable your data gets.

🏝️ The Regulatory Arbitrage Spotter

R3 Bio moved to the Caribbean specifically to dodge US regulations. This pattern — companies fleeing to permissive jurisdictions to do controversial biotech — is happening constantly. Somebody needs to be the person who maps WHICH countries allow WHAT, and sells that intelligence to startups looking for a legal home. Think of it as real estate scouting, but for biotech companies that can’t operate in their home country.

:brain: Example: A 28-year-old paralegal in Manila, Philippines builds a spreadsheet comparing biotech regulations across 40 countries (cloning laws, gene therapy rules, animal testing requirements) using public government databases and WHO regulatory frameworks. Packages it as a $500 one-time purchase for biotech founders. Sells 22 copies in the first month through targeted outreach in longevity Telegram groups and Discord servers.

:chart_increasing: Timeline: First sale in 8 days. Hot window is ~3 months while regulatory arbitrage is in the news. Update it quarterly and it becomes an annual subscription product.

🧬 The 'Is My DNA Safe' Audit

Here’s the angle nobody’s talking about: if growing a clone of someone becomes even theoretically possible, DNA security suddenly matters in a whole new way. Right now, millions of people have their full genome sitting in 23andMe, AncestryDNA, and various research databases — some of which have already been hacked. Offer a “DNA exposure audit” service that tells people exactly where their genetic data lives, who has access, and how to request deletion. Combine GDPR/privacy law knowledge with basic genomics literacy.

:brain: Example: A 24-year-old cybersecurity student in Berlin, Germany creates a simple web tool using public APIs that checks if someone’s genetic data appears in known breached databases. Charges €15 per scan. Gets featured in a German tech publication after the R3 Bio story breaks. 1,400 scans in the first month = €21,000.

:chart_increasing: Timeline: First revenue in 5 days if you launch alongside the news cycle. Sustainable for 2-3 months as a standalone tool, longer if you pivot into ongoing DNA privacy monitoring.

🛠️ Follow-Up Actions
Want To… Do This
Understand the actual science Read the full MIT Technology Review investigation
Check if your DNA is exposed Search your email on Have I Been Pwned and request data deletion from 23andMe
Follow longevity industry moves Track the Longevity Technology news site
Understand cloning regulation Review the UN Declaration on Human Cloning
Research bioethics frameworks Start with the Nuffield Council on Bioethics

:high_voltage: Quick Hits

Want… Do…
:dna: Protect your DNA Request deletion from consumer genomics services NOW
:open_book: Understand the tech Read Futurism’s breakdown of what’s real vs science fiction
:money_bag: Spot the money angle Watch longevity VC funding rounds — this sector is about to explode with controversy AND cash
:locked: Check your genetic exposure Run your email through Have I Been Pwned for genomics breaches
:brain: Form your own opinion Read the actual bioethics arguments before the hot takes bury them

A guy who cloned some mice is pitching billionaires on growing your spare body in a Caribbean lab. And somehow, this isn’t a Netflix show. It’s a Series A.

1 Like